Impact of Whole-Body Radiation Dose on Response and Toxicity in Patients With Neuroblastoma After Therapy With (131)I-Metaiodobenzylguanidine (MIBG)

BACKGROUND. (131)I-metaiodobenzylguanidine ((131)I-MIBG) is a targeted radiopharmaceutical for patients with neuroblastoma. Despite its tumor-specific uptake, the treatment with (131)I-MIBG results in whole-body radiation exposure. Our aim was to correlate whole-body radiation dose (WBD) from (131)I...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pediatr Blood Cancer
Main Authors: Trieu, Megan, DuBois, Steven G., Pon, Elizabeth, Nardo, Lorenzo, Hawkins, Randall A., Marachelian, Araz, Twist, Clare J., Park, Julie R., Matthay, Katherine K.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7523914/
https://ncbi.nlm.nih.gov/pubmed/26506090
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.25816
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados